Company Encyclopedia
View More
name
Rydx S&P Mc 400 Pure Grw
RFG.US
News
View More

An S&P 500 shakeup is due soon. These stocks could join the index.

Marvell Technology is newly eligible for the S&P 500, having met financial viability requirements. The index committee may announce changes soon, possibly adding Marvell or other candidates like Comfort Systems USA, Ciena, and Carvana. The committee's discretion and timing are uncertain, with potential updates expected before Dec. 22. Strategy's inclusion is less likely due to digital-asset concerns.

Dow Jones·
US
FIX
-1.26%
US
MRVL
+0.43%
US
CVNA
+0.92%
Dow Jones·
US
FIX
-1.26%
US
MRVL
+0.43%
US
CVNA
+0.92%

VP Howell Sells 1,000 ($996.2K) Of Comfort Systems USA Inc [FIX]

Howell Laura Finley Vice President of Comfort Systems USA Inc [FIX] filed a Form 4 on December 5, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/4/25TransactionSaleShares1,000Price$996.16Value$996,163Ending Holdings: 7,938 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Reuters·
US
FIX
-1.26%
Reuters·
US
FIX
-1.26%

Laura Finley Howell, SVP & General Counsel, Sells Comfort Systems USA Inc. Common Shares

Laura Finley Howell, SVP & General Counsel of Comfort Systems USA Inc., has sold common shares of the company. The transaction was reported via EDGAR by the U.S. SEC on December 5, 2025. This information is for informational purposes only and not financial advice.

Reuters·
US
FIX
-1.26%
Reuters·
US
FIX
-1.26%

Medpace (NASDAQ:MEDP) Stock Price Down 3.7% After Insider Selling

Medpace's stock price fell by 3.7% following insider selling by CEO August J. Troendle, who sold significant shares over several transactions. The stock traded as low as $530.96, with a notable decrease in trading volume. Analysts have mixed ratings on the stock, with a consensus 'Hold' rating and an average price target of $487.18. Medpace reported strong quarterly earnings, beating estimates, and has set its FY 2025 guidance at 14.600-14.860 EPS.

Market Beat·
US
MEDP
+0.15%
Market Beat·
US
MEDP
+0.15%

Trending | HIMS Surges 7% on Thursday, Some Call options Soar 583%

On December 4, Eastern Time, Hims & Hers Health options saw a total of 86385 contracts traded, with calls accounting for 70% and puts making up 29%.

LB Option·
US
HIMS
-1.37%
LB Option·
US
HIMS
-1.37%
© 2025 Longbridge｜Disclaimer